Latest Period
Q2 2026
Security Snapshot
Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX) Institutional Ownership
CUSIP: 34962G208
13F Institutional Holders and Ownership History from Q3 2024 to Q2 2026
Institutions Reporting
85
Shares (Excl. Options)
20,362,406
Price
$21.25
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- FBRX on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 20,362,406
- Total 13F value
- $432,725,429
- Portfolio coverage rank
- 0%
- Share change
- +6,642,530
- Value change
- +$139,177,583
- Number of holders
- 85
- Shares outstanding
- 20,402,903
- SEC-reported price per share
- $76.50
- Insider filing price
- $76.50
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- FBRX - Forte Biosciences, Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 34962G208.
- 85 institutions reported positions in Q2 2026.
- 16 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 68 to 85 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $350,237,410 to $432,725,429.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 85 institutions filings for Q2 2026.
Security key
34962G208
Latest holder period
Q2 2026
13F holders
85
13D/G owners
16
CIK / CUSIP context first
Open Q2 2026 holders
FBRX full holder history
Forte Biosciences, Inc. SEC filings
Forte Biosciences, Inc. company facts
Forte Biosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 34962G208:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
16
Security
FBRX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | 10% | -22% | $34,865,724 | +$7,849,247 | 2,110,516 | +29% | Federated Hermes, Inc. | 30 Jun 2026 |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 10% | 0% | $13,378,307 | +$6,618,184 | 1,268,086 | +98% | TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 30 Jun 2025 |
| ORBIMED ADVISORS LLC | 6.2% | -22% | $55,810,918 | +$33,309,718 | 1,264,980 | +148% | ORBIMED ADVISORS LLC | 30 Jun 2026 |
| BlackRock, Inc. | 5.9% | $25,598,430 | 1,204,632 | BlackRock, Inc. | 30 Jun 2026 | |||
| Affinity Asset Advisors, LLC | 5.6% | -16% | $50,534,651 | +$13,696,039 | 1,145,391 | +37% | Affinity Asset Advisors, LLC | 30 Jun 2026 |
| ALGER ASSOCIATES INC | 4.6% | -56% | $41,274,878 | +$13,731,379 | 935,514 | +50% | Alger Associates, Inc. | 31 Jul 2026 |
| Point72 Asset Management, L.P. | 6.3% | $21,132,810 | 792,976 | Point72 Asset Management, L.P. | 12 Jan 2026 | |||
| Adage Capital Management, L.P. | 3.4% | $30,884,000 | 700,000 | Adage Capital Management, L.P. | 30 Jun 2026 | |||
| MILLENNIUM MANAGEMENT LLC | 3.2% | -40% | $12,147,389 | -$7,545,465 | 655,199 | -38% | Millennium Management LLC | 30 Jun 2026 |
| Ikarian Capital, LLC | 5% | -45% | $6,516,387 | +$89,063 | 617,667 | +1.4% | Ikarian Capital, LLC | 30 Jun 2025 |
| Janus Henderson Group Ltd. | 2.5% | -75% | $22,987,226 | -$38,215,067 | 521,016 | -62% | JANUS HENDERSON GROUP Ltd. | 31 Jul 2026 |
| Oliveira Steven Michael | 2.4% | -62% | $6,797,265 | -$2,993,786 | 300,100 | -31% | Oliveira Steven Michael | 08 Jan 2026 |
| GLAZER CAPITAL, LLC | 1.5% | $13,236,000 | 300,000 | Glazer Capital, LLC | 04 Aug 2026 | |||
| PERCEPTIVE ADVISORS LLC | 2.5% | $1,209,840 | 163,935 | Perceptive Advisors LLC | 31 Dec 2024 | |||
| BIOTECHNOLOGY VALUE FUND L P | 0.5% | -95% | $980,250 | -$8,674,080 | 65,350 | -90% | BVF PARTNERS L P/IL | 30 Sep 2025 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.8% | -87% | $567,495 | -$369,187 | 53,791 | -39% | Boothbay Fund Management, LLC | 30 Jun 2025 |
As of 30 Jun 2026, 85 institutional investors reported holding 20,362,406 shares of Forte Biosciences, Inc. - Common Stock, par value $0.001 per share (FBRX). This represents 100% of the company’s total 20,402,903 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
91%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FEDERATED HERMES, INC. | 10% | 2,110,516 | +20% | 0.06% | $44,848,465 |
| ORBIMED ADVISORS LLC | 7.7% | 1,577,705 | +32% | 0.64% | $33,526,231 |
| FRED ALGER MANAGEMENT, LLC | 7.1% | 1,439,697 | +13% | 0.1% | $30,593,561 |
| Jupiter Topco LLC | 6.7% | 1,373,060 | 0% | 0.01% | $29,204,986 |
| BlackRock, Inc. | 6% | 1,222,862 | +1755% | 0% | $25,985,818 |
| Affinity Asset Advisors, LLC | 5.6% | 1,145,391 | +13% | 1.2% | $24,339,559 |
| MPM BIOIMPACT LLC | 4.8% | 987,448 | -1.3% | 1.3% | $20,983,270 |
| TCG Crossover Management, LLC | 4.5% | 920,000 | 0.47% | $19,550,000 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.2% | 861,737 | +62% | 0% | $18,311,911 |
| Woodline Partners LP | 3.5% | 712,753 | +115% | 0.05% | $15,146,001 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.4% | 700,000 | -26% | 0.02% | $14,875,000 |
| Integral Health Asset Management, LLC | 3.3% | 675,000 | +350% | 0.59% | $14,343,750 |
| MILLENNIUM MANAGEMENT LLC | 3.2% | 655,199 | +94% | 0.01% | $13,922,979 |
| CITADEL ADVISORS LLC | 2.7% | 547,415 | +135% | 0.01% | $11,632,569 |
| FMR LLC | 2.5% | 502,826 | +48% | 0% | $10,685,053 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.3% | 473,280 | +277% | 0% | $10,059,528 |
| AMERIPRISE FINANCIAL INC | 2.1% | 418,891 | +275% | 0% | $8,901,434 |
| Cable Car Capital, LP | 2% | 400,000 | 0% | 0.18% | $8,500,000 |
| STATE STREET CORP | 1.6% | 328,522 | +499% | 0% | $6,981,093 |
| Candriam S.C.A. | 1.5% | 303,100 | +257% | 0.03% | $6,434,678 |
| Boxer Capital Management, LLC | 1.3% | 274,500 | 0.44% | $5,833,125 | |
| Trails Edge Capital Partners, LP | 1.3% | 273,181 | 0.92% | $5,805,097 | |
| SPHERA FUNDS MANAGEMENT LTD. | 1.2% | 249,693 | +35% | 0.76% | $5,305,976 |
| Squadron Capital Management LLC | 1.1% | 225,000 | 1.6% | $4,781,250 | |
| AWM Investment Company, Inc. | 1.1% | 222,500 | +11% | 0.41% | $4,728,125 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
8
Latest
Q2 2026
Rows shown
1-8 of 8
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 20,362,406 | $432,725,429 | +$139,177,583 | $21.25 | 85 |
| 2026 Q1 | 13,521,022 | $350,237,410 | +$50,671,169 | $25.90 | 68 |
| 2025 Q4 | 11,522,905 | $314,510,108 | +$55,513,195 | $27.27 | 59 |
| 2025 Q3 | 10,343,866 | $155,080,846 | +$6,727,909 | $15.00 | 42 |
| 2025 Q2 | 9,809,779 | $127,063,335 | +$62,289,077 | $12.93 | 33 |
| 2025 Q1 | 5,034,489 | $39,316,245 | +$4,704,465 | $7.76 | 29 |
| 2024 Q4 | 4,275,821 | $97,104,372 | +$81,936,549 | $22.71 | 26 |
| 2024 Q3 | 736,630 | $4,120,236 | +$4,082,162 | $5.59 | 23 |